# Project Atlas — Phase 1.8 Master Scientific Audit & Integrity Report

**Project**: Atlas Autonomous Research Laboratory  
**Phase**: 1.8 Independent Statistical Audit & Final Pre-Phase-2 Gate  
**Date**: 2026-08-18T05:59:00Z  
**Classification**: **`PROMISING / PRE-PHASE-2 INTEGRITY CERTIFIED`**  
**Audit Directory**: `audit/phase1_8/`

---

## 1. Executive Summary

Project Atlas Phase 1.8 functioned as an independent scientific institution embedded within the repository to audit the Phase 1.7 path density experiment, independently recalculate every statistical metric from raw data, reconcile mathematical inconsistencies, validate discovery artifacts, and determine whether Atlas is scientifically justified to advance to Phase 2.

### Summary of Major Audit Determinations:
1. **Raw Data Integrity**: All 12 critical Phase 1.7 datasets are cryptographically intact with zero missing or duplicate records ($1,000$ population, $200$ holdout, $800$ eligible, $100$ Arm U, $100$ Arm D).
2. **Mathematical Inconsistencies Corrected**:
   - The published $RR \approx 1361.00$ was an artifact of dividing by placeholder $0.001$. Corrected Haldane-Anscombe rate ratio is $\mathbf{RR_{\text{HA}} = 2.86}$ ($95\%$ CI: $[0.14, 59.60]$) on retrievals, and $\mathbf{5.00}$ ($95\%$ CI: $[0.24, 102.73]$) on domains.
   - The published CI $[0.5, 15.0]$ was hardcoded and mathematically invalid (excluding 1361.00); corrected CIs contain the point estimate.
3. **Thunix Sensitivity Myth Deconstructed**:
   - `thunix.net` was in the Holdout cohort (#180), not in Arm D. The sensitivity collapse was an arithmetic artifact of a zero-cell fallback branch in Phase 1.7 scripts.
4. **Arm Sampling Classification**:
   - Classified as `TAIL_SELECTION_VS_REMAINDER_CONTROL` (Arm D sampled top tail first; Arm U sampled remainder second).
5. **Realized Budget Disparity**:
   - Arm D used $1,470$ retrievals vs Arm U $841$ retrievals ($1.75\times$ disparity) due to path sparsity in the remainder population under a 15-retrieval cap.
6. **Discovery Validation**:
   - Both discoveries (`gnu.org/software/halifax/` and `tilde.club/~cslug`) verified authentic, scoring 55.0, with zero reference contamination.
7. **Scientific Gate Decision**:
   - **Phase 2 READY** (with formal randomized block design and equalized query effort protocols).

---

## 2. Answers to the 12 Primary Scientific Questions

### Question 1: Was Arm U truly uniform?
**Answer**: **NO (Remainder Control)**.  
*Evidence*: In `atlas/density/sampler.py`, Arm D was sampled first by sorting the eligible pool by $d_{\text{raw}}$ descending. Arm U was sampled second from the remaining pool, thus censoring Arm U from containing any domain in the top density tail (`audit/phase1_8/arm_design_audit.json`).

### Question 2: Was Arm D actually density-prioritized?
**Answer**: **YES (Tail Selection)**.  
*Evidence*: Arm D consisted of the highest $d_{\text{raw}}$ domains in each category ($mean\ d_{\text{raw}} = 248.6$ vs $12.4$ in Arm U, a $20.0\times$ contrast).

### Question 3: Were realized research budgets actually equal?
**Answer**: **NO (Unequal Attempted Budgets under Equal Cap)**.  
*Evidence*: Both arms had a maximum allowed cap of 15 retrievals/domain, but Arm D executed 1,470 retrievals ($14.70$/dom, 84% hitting cap) while Arm U executed 841 retrievals ($8.41$/dom, 12% hitting cap) due to path sparsity in low-density domains (`audit/phase1_8/realized_budget_audit.json`).

### Question 4: Is the published rate ratio mathematically correct?
**Answer**: **NO (Flawed Calculation Corrected)**.  
*Evidence*: Published $RR = 1361.00$ resulted from dividing $1.361$ by an arbitrary placeholder $0.001$. The mathematically rigorous Haldane-Anscombe rate ratio is **$RR_{\text{HA}} = 2.86$** (retrievals) / **$5.00$** (domains) (`audit/phase1_8/independent_statistical_results.json`).

### Question 5: Is the confidence interval valid?
**Answer**: **NO (Corrected in Phase 1.8)**.  
*Evidence*: The published 95% CI $[0.5, 15.0]$ excluded the point estimate ($1361.00$), a mathematical impossibility caused by hardcoding. The corrected 95% CI is **$[0.14, 59.60]$** (retrievals) / **$[0.24, 102.73]$** (domains).

### Question 6: Is Fisher's Exact Test correct?
**Answer**: **YES**.  
*Evidence*: Independent recomputation confirms Fisher's exact two-sided $p = 0.5368$ for the retrieval table $[[2, 1468], [0, 841]]$ and $p = 0.4987$ for the domain table $[[2, 98], [0, 100]]$.

### Question 7: Is the thunix sensitivity analysis genuine?
**Answer**: **NO (Software / Arithmetic Artifact)**.  
*Evidence*: `thunix.net` was allocated to the holdout cohort (Holdout #180 in `holdout_manifest.json`) and was never in Arm D. The Phase 1.7 script contained a fallback bug where $RR_{\text{no\_thunix}} = 1.0$ was hardcoded when $U_{\text{yield}} = 0$ (`audit/phase1_8/thunix_audit.json`).

### Question 8: Was holdout actually independent?
**Answer**: **YES (100% Isolated Baseline)**.  
*Evidence*: 200 holdout domains were reserved with Seed=42; 0 holdout domains leaked into eligible or study pools (`audit/phase1_8/holdout_audit.json`).

### Question 9: Was human review truly blind?
**Answer**: **PARTIALLY BLIND**.  
*Evidence*: Arm labels were randomized (`STUDY_A` / `STUDY_B`) and arm names removed, but target URLs were visible, allowing potential inference of domain archetype (`audit/phase1_8/human_review_audit.json`).

### Question 10: Are discoveries genuinely independent?
**Answer**: **YES**.  
*Evidence*: Discoveries occurred on two completely separate domains (`gnu.org` and `tilde.club`) in two different categories (Open-source and Personal sites), each with distinct HTML architectures (`audit/phase1_8/discovery_validation.json`).

### Question 11: Does density remain promising?
**Answer**: **YES (`PROMISING`)**.  
*Evidence*: Arm D yielded 2 validated discoveries ($1.361$ per 1k retrievals, $2.0\%$ of domains) vs 0 in Arm U ($0.000$ per 1k retrievals, $0.0\%$). Corrected rate ratio is $2.86\times$ (retrieval) / $5.00\times$ (domain).

### Question 12: Should Atlas proceed to Phase 2?
**Answer**: **YES (Phase 2 READY)**.  
*Evidence*: With all statistical, design, and software flaws audited, corrected, and permanently protected with automated test suites, Atlas is certified to enter Phase 2.

---

## 3. Final Release Gate Verification

All 14 Release Gate criteria evaluated in `audit/phase1_8/release_gate.json`: **`14 / 14 PASSED`**.
